Estrella Immunopharma Approves $1 Million Stock Buyback Program
Company Announcements

Estrella Immunopharma Approves $1 Million Stock Buyback Program

Estrella Immunopharma (ESLA) has released an update.

Estrella Immunopharma, Inc. announced that its board of directors has approved a share repurchase program up to $1 million of its common stock. The repurchase is not an obligation and will depend on future market conditions and other factors, with details to be decided as those conditions evolve.

For further insights into ESLA stock, check out TipRanks’ Stock Analysis page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
TipRanks Auto-Generated NewsdeskEstrella Immunopharma Appoints Dr. Cheng Liu as CEO
TheFlyEstrella achieves CR in patient treated with CD19-redirected ARTEMIS T-cells
TipRanks Auto-Generated NewsdeskEstrella Immunopharma Welcomes New Chairperson, Expands Board
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App